妊娠前或妊娠后临床诊断甲状腺疾病女性的丹麦生物样本库早期妊娠甲状腺功能检测异常研究
基于丹麦国家出生队列(DNBC)1997至2003年间单胎活产孕妇,纳入全国健康登记中妊娠前和/或妊娠后五年内登记甲状腺疾病者(n=2445)及12%随机样本(n=7624),用免疫分析法检测孕期储存血清的促甲状腺激素和游离甲状腺素。随机样本早期妊娠甲状腺功能异常频率为12.5%,临床诊断甲状腺疾病者为35.7%(当前治疗者55.7%),血液采样后临床诊断甲状腺疾病者中三分之一存在未被识别的甲状腺功能障碍。
要点
- 随机样本早期妊娠甲状腺功能异常频率为12.5%。
- 临床诊断甲状腺疾病者异常频率为35.7%,当前治疗者为55.7%。
- 采样后诊断甲状腺疾病者中三分之一存在未被识别的甲状腺功能障碍,以未识别甲状腺功能减退症最常见(52.0%)。
核心结论
- 当前接受甲状腺疾病治疗的丹麦孕妇中超过50%的促甲状腺激素和/或游离甲状腺素超出孕周特异性参考范围。
- 妊娠后临床诊断甲状腺疾病女性的早期妊娠未被识别甲状腺功能障碍频率也较高。
研究设计与样本
- 基于丹麦国家出生队列(DNBC)的人群研究,纳入1997至2003年间单胎活产且早孕期采血的孕妇。
- 纳入全国健康登记中妊娠前和/或妊娠后五年内登记甲状腺疾病者(n=2445)及队列12%随机样本(n=7624)。
- 采用免疫分析法检测丹麦国家生物样本库储存血清的促甲状腺激素和游离甲状腺素,按方法和孕周特异性参考范围分类甲状腺功能检测异常。
主要发现
- 随机样本早期妊娠甲状腺功能异常频率为12.5%。
- 临床诊断甲状腺疾病(采样前或采样后)者早期妊娠甲状腺功能异常频率为35.7%,当前治疗者为55.7%。
- 血液采样后临床诊断甲状腺疾病者中三分之一在早期妊娠血样中存在未被识别的甲状腺功能障碍。
- 采样后诊断甲状腺功能减退症女性中未被识别甲状腺功能减退症最常见,占52.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Maternal thyroid disease may complicate pregnancy. A high frequency of abnormal thyroid function test results in pregnant women with known thyroid disease has been reported, but the frequency of unidentified thyroid dysfunction in women first clinically diagnosed with thyroid disease after a pregnancy is not known. METHODS: This was a population-based study of pregnant women in the Danish National Birth Cohort (DNBC) who had a blood sample drawn in early pregnancy and terminated the pregnancy with a singleton live-birth in the period between 1997 and 2003. Participants were all women in the DNBC who had a registration of thyroid disease before and/or up to five years after the pregnancy in nationwide health registers (n = 2445) and a 12% random sample of all women in the cohort (n = 7624). Thyrotropin and free thyroxine were measured with an immunoassay in sera stored in the Danish National Biobank. Method- and pregnancy week-specific references ranges were used for classification of thyroid function test abnormalities. RESULTS: The frequency of abnormal thyroid function in early pregnancy was 12.5% in the random sample and 35.7% among women clinically diagnosed with thyroid disease before or after blood sampling (55.7% among women on current treatment). One third of women clinically diagnosed with thyroid disease after blood sampling had unidentified thyroid dysfunction in the early pregnancy blood sample (most frequently [52.0%] unidentified hypothyroidism in women with a later diagnosis of hypothyroidism). CONCLUSIONS: More than 50% of Danish pregnant women on current treatment for thyroid disease had thyrotropin and/or free thyroxine outside the week-specific reference ranges, and the frequency of unidentified early pregnancy thyroid dysfunction in women clinically diagnosed after the pregnancy was also high.
引用
- Andersen SL, Olsen J. Early Pregnancy Thyroid Function Test Abnormalities in Biobank Sera from Women Clinically Diagnosed with Thyroid Dysfunction Before or After Pregnancy. Thyroid. 2016. PMID: 27841706. doi:10.1089/thy.2016.0542
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。